Price
CHART BY
Historical dividends and forecast
The next dividend will be paid on 01.07.2026
0.355
CHART BY
Frequently asked questions
What is Daiichi Sankyo ADR's market capitalization?
The market capitalization of Daiichi Sankyo ADR is $209.76M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Daiichi Sankyo ADR's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Daiichi Sankyo ADR is 16.49. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for Daiichi Sankyo ADR?
Daiichi Sankyo ADR's Earnings Per Share (EPS) over the trailing twelve months (TTM) is 0.006874. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Daiichi Sankyo ADR's stock?
Currently, 16 analysts cover Daiichi Sankyo ADR's stock, with a consensus target price of $0.196. Analyst ratings provide insights into the stock's expected performance.
What is Daiichi Sankyo ADR's revenue over the trailing twelve months?
Over the trailing twelve months, Daiichi Sankyo ADR reported a revenue of $86.07M.
What is the EBITDA for Daiichi Sankyo ADR?
Daiichi Sankyo ADR's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $16.22M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Daiichi Sankyo ADR?
Daiichi Sankyo ADR has a free cash flow of -$467.19K. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Daiichi Sankyo ADR have, and what sector and industry does it belong to?
Daiichi Sankyo ADR employs approximately 19,765 people. It operates in the Health Care sector, specifically within the Major Pharmaceuticals industry.
Financials
- Market Cap
- $209.76M
- EPS (TTM)
- 0.006874
- P/E ratio (TTM)
- 16.49
- Revenue (TTM)
- $86.07M
- EBITDA (TTM)
- $16.22M
- Free Cashflow (TTM)
- -$467.19K
Analyst Ratings
The price target is $0.196 and the stock is covered by 16 analysts.
Buy
15
Hold
1
Sell
0
Information
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. Its products include drugs for the field of oncology such as Trastuzumab deruxtecan, Anti-HER3-ADC, Quizartinib, Milademetan, Valemetostat, Pexidartinib, Edoxaban, Prasugel, and Microgabalin. The company was founded in 2005 and is headquartered in Tokyo, Japan.
- Employees
- 19,765
- Industries
- Major Pharmaceuticals
- Sector
- Health Care
Identifier
- Primary Ticker
- DSNKY
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet